[go: up one dir, main page]

MXPA05011294A - Compuestos de fosfonato anti-inflamatorios. - Google Patents

Compuestos de fosfonato anti-inflamatorios.

Info

Publication number
MXPA05011294A
MXPA05011294A MXPA05011294A MXPA05011294A MXPA05011294A MX PA05011294 A MXPA05011294 A MX PA05011294A MX PA05011294 A MXPA05011294 A MX PA05011294A MX PA05011294 A MXPA05011294 A MX PA05011294A MX PA05011294 A MXPA05011294 A MX PA05011294A
Authority
MX
Mexico
Prior art keywords
inflammatory
compounds
phosphonate compounds
phosphonate
administration
Prior art date
Application number
MXPA05011294A
Other languages
English (en)
Inventor
Ralph F Hirschmann
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of MXPA05011294A publication Critical patent/MXPA05011294A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548—Phosphates or phosphonates, e.g. bone-seeking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650905—Six-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se refiere a compuestos anti-inflamatorios sustituidos con fosforo, a composiciones que contienen estos compuestos, y a metodos terapeuticos que incluyen la administracion de estos compuestos, asi como a procedimientos e intermediarios utiles para preparar estos compuestos.
MXPA05011294A 2003-04-25 2004-04-26 Compuestos de fosfonato anti-inflamatorios. MXPA05011294A (es)

Applications Claiming Priority (152)

Application Number Priority Date Filing Date Title
US46574903P 2003-04-25 2003-04-25
US46548003P 2003-04-25 2003-04-25
US46564003P 2003-04-25 2003-04-25
US46533203P 2003-04-25 2003-04-25
US46556003P 2003-04-25 2003-04-25
US46575603P 2003-04-25 2003-04-25
US46548103P 2003-04-25 2003-04-25
US46537703P 2003-04-25 2003-04-25
US46565803P 2003-04-25 2003-04-25
US46543303P 2003-04-25 2003-04-25
US46553203P 2003-04-25 2003-04-25
US46574603P 2003-04-25 2003-04-25
US46534203P 2003-04-25 2003-04-25
US46563203P 2003-04-25 2003-04-25
US46537303P 2003-04-25 2003-04-25
US46568303P 2003-04-25 2003-04-25
US46569503P 2003-04-25 2003-04-25
US46540603P 2003-04-25 2003-04-25
US46542003P 2003-04-25 2003-04-25
US46542203P 2003-04-25 2003-04-25
US46547903P 2003-04-25 2003-04-25
US46553103P 2003-04-25 2003-04-25
US46542403P 2003-04-25 2003-04-25
US46562003P 2003-04-25 2003-04-25
US46568203P 2003-04-25 2003-04-25
US46584403P 2003-04-25 2003-04-25
US46533503P 2003-04-25 2003-04-25
US46541903P 2003-04-25 2003-04-25
US46563803P 2003-04-25 2003-04-25
US46558103P 2003-04-25 2003-04-25
US46538003P 2003-04-25 2003-04-25
US46544903P 2003-04-25 2003-04-25
US46554703P 2003-04-25 2003-04-25
US46545203P 2003-04-25 2003-04-25
US49330903P 2003-08-07 2003-08-07
US49330203P 2003-08-07 2003-08-07
US49330303P 2003-08-07 2003-08-07
US49331003P 2003-08-07 2003-08-07
US49537503P 2003-08-15 2003-08-15
US49547103P 2003-08-15 2003-08-15
US49538003P 2003-08-15 2003-08-15
US49559703P 2003-08-15 2003-08-15
US49552903P 2003-08-15 2003-08-15
US49545503P 2003-08-15 2003-08-15
US49553203P 2003-08-15 2003-08-15
US49575403P 2003-08-15 2003-08-15
US49546003P 2003-08-15 2003-08-15
US49527603P 2003-08-15 2003-08-15
US49541603P 2003-08-15 2003-08-15
US49574903P 2003-08-15 2003-08-15
US49529503P 2003-08-15 2003-08-15
US49568003P 2003-08-15 2003-08-15
US49566103P 2003-08-15 2003-08-15
US49539803P 2003-08-15 2003-08-15
US49574803P 2003-08-15 2003-08-15
US49567903P 2003-08-15 2003-08-15
US49539303P 2003-08-15 2003-08-15
US49538903P 2003-08-15 2003-08-15
US49569103P 2003-08-15 2003-08-15
US49553703P 2003-08-15 2003-08-15
US49556303P 2003-08-15 2003-08-15
US49542503P 2003-08-15 2003-08-15
US49547203P 2003-08-15 2003-08-15
US49566003P 2003-08-15 2003-08-15
US49553003P 2003-08-15 2003-08-15
US49527403P 2003-08-15 2003-08-15
US49575703P 2003-08-15 2003-08-15
US49545603P 2003-08-15 2003-08-15
US49536603P 2003-08-15 2003-08-15
US49542703P 2003-08-15 2003-08-15
US49561403P 2003-08-15 2003-08-15
US49541403P 2003-08-15 2003-08-15
US49553303P 2003-08-15 2003-08-15
US51445003P 2003-10-24 2003-10-24
US51432403P 2003-10-24 2003-10-24
US51420003P 2003-10-24 2003-10-24
US51356303P 2003-10-24 2003-10-24
US51446603P 2003-10-24 2003-10-24
US51394703P 2003-10-24 2003-10-24
US51405403P 2003-10-24 2003-10-24
US51433403P 2003-10-24 2003-10-24
US51358903P 2003-10-24 2003-10-24
US51356203P 2003-10-24 2003-10-24
US51409803P 2003-10-24 2003-10-24
US51417403P 2003-10-24 2003-10-24
US51359203P 2003-10-24 2003-10-24
US51446403P 2003-10-24 2003-10-24
US51395003P 2003-10-24 2003-10-24
US51356103P 2003-10-24 2003-10-24
US51428003P 2003-10-24 2003-10-24
US51436003P 2003-10-24 2003-10-24
US51417503P 2003-10-24 2003-10-24
US51411303P 2003-10-24 2003-10-24
US51353003P 2003-10-24 2003-10-24
US51420503P 2003-10-24 2003-10-24
US51392403P 2003-10-24 2003-10-24
US51411003P 2003-10-24 2003-10-24
US51397303P 2003-10-24 2003-10-24
US51407503P 2003-10-24 2003-10-24
US51409703P 2003-10-24 2003-10-24
US51420203P 2003-10-24 2003-10-24
US51439403P 2003-10-24 2003-10-24
US51397903P 2003-10-24 2003-10-24
US51394803P 2003-10-24 2003-10-24
US51397503P 2003-10-24 2003-10-24
US51413103P 2003-10-24 2003-10-24
US51414303P 2003-10-24 2003-10-24
US51394403P 2003-10-24 2003-10-24
US51358803P 2003-10-24 2003-10-24
US51414403P 2003-10-24 2003-10-24
US51410703P 2003-10-24 2003-10-24
US51420103P 2003-10-24 2003-10-24
US51396103P 2003-10-24 2003-10-24
US51405103P 2003-10-24 2003-10-24
US51402103P 2003-10-24 2003-10-24
US51442403P 2003-10-24 2003-10-24
US51411103P 2003-10-24 2003-10-24
US51420603P 2003-10-24 2003-10-24
US51432503P 2003-10-24 2003-10-24
US51448103P 2003-10-24 2003-10-24
US51424403P 2003-10-24 2003-10-24
US51425803P 2003-10-24 2003-10-24
US51357903P 2003-10-24 2003-10-24
US51404403P 2003-10-24 2003-10-24
US51395103P 2003-10-24 2003-10-24
US51359303P 2003-10-24 2003-10-24
US51394503P 2003-10-24 2003-10-24
US51408503P 2003-10-24 2003-10-24
US51397703P 2003-10-24 2003-10-24
US51394603P 2003-10-24 2003-10-24
US51420303P 2003-10-24 2003-10-24
US51398203P 2003-10-24 2003-10-24
US51439303P 2003-10-24 2003-10-24
US51416103P 2003-10-24 2003-10-24
US51414003P 2003-10-24 2003-10-24
US51397003P 2003-10-24 2003-10-24
US51395303P 2003-10-24 2003-10-24
US51353103P 2003-10-24 2003-10-24
US51416003P 2003-10-24 2003-10-24
US51413003P 2003-10-24 2003-10-24
US51452203P 2003-10-24 2003-10-24
US51432603P 2003-10-24 2003-10-24
US51411603P 2003-10-24 2003-10-24
US51420403P 2003-10-24 2003-10-24
US51407203P 2003-10-24 2003-10-24
US51445303P 2003-10-24 2003-10-24
US51429803P 2003-10-24 2003-10-24
US51397603P 2003-10-24 2003-10-24
US51397103P 2003-10-24 2003-10-24
US53216003P 2003-12-22 2003-12-22
US53194003P 2003-12-22 2003-12-22
PCT/US2004/013198 WO2004100960A2 (en) 2003-04-25 2004-04-26 Anti-inflammatory phosphonate compounds

Publications (1)

Publication Number Publication Date
MXPA05011294A true MXPA05011294A (es) 2006-03-15

Family

ID=39767037

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011294A MXPA05011294A (es) 2003-04-25 2004-04-26 Compuestos de fosfonato anti-inflamatorios.

Country Status (5)

Country Link
EP (1) EP1663254A2 (es)
KR (1) KR20060028632A (es)
MX (1) MXPA05011294A (es)
NO (1) NO20055612L (es)
WO (1) WO2004100960A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004082629A2 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7429565B2 (en) 2003-04-25 2008-09-30 Gilead Sciences, Inc. Antiviral phosphonate analogs
HRP20070078A2 (hr) 2004-07-27 2007-05-31 Gilead Sciences Fosfonatni analozi spojeva koji inhibiraju hiv
EP1804823A4 (en) 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
JP2008514701A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7951789B2 (en) 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
PT2307435E (pt) 2008-07-08 2012-09-19 Gilead Sciences Inc Sais de compostos inibidores de vih
AR094621A1 (es) 2010-04-01 2015-08-19 Idenix Pharmaceuticals Inc Compuestos y composiciones farmacéuticas para el tratamiento de infecciones virales
CN103842369A (zh) 2011-03-31 2014-06-04 埃迪尼克斯医药公司 用于治疗病毒感染的化合物和药物组合物
US20190022116A1 (en) 2014-12-26 2019-01-24 Emory University N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto
WO2019027920A1 (en) 2017-08-01 2019-02-07 Gilead Sciences, Inc. CRYSTALLINE FORMS OF ETHYL ((S) - (((((2R, 5R) -5- (6-AMINO-9H-PURIN-9-YL) -4-FLUORO-2,5-DIHYDROFURAN-2-YL) OXY ) METHYL) (PHENOXY) PHOSPHORYL) -L-ALANINATE (GS-9131) FOR THE TREATMENT OF VIRAL INFECTIONS
DK3706762T3 (da) 2017-12-07 2024-12-16 Univ Emory N4-hydroxycytidin og derivater og antivirale anvendelser relateret dertil
CN115353932B (zh) * 2022-09-07 2023-10-20 江门市和馨香精技术有限公司 用于控制皂化速度的香精组合物及其应用、冷制皂

Also Published As

Publication number Publication date
WO2004100960A8 (en) 2008-04-24
NO20055612L (no) 2006-01-20
NO20055612D0 (no) 2005-11-25
KR20060028632A (ko) 2006-03-30
WO2004100960A2 (en) 2004-11-25
EP1663254A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
WO2005002626A3 (en) Therapeutic phosphonate compounds
MXPA05011296A (es) Conjugados de fosfonato inhibidores de la cinasa.
WO2004096285A3 (en) Anti-infective phosphonate conjugates
WO2004096286A3 (en) Antiviral phosphonate analogs
TW200618804A (en) Phosphonate analogs of HIV inhibitor compounds
TW200614996A (en) Antiviral compounds
BRPI0409680A (pt) análogos de fosfonato anti-cáncer
TW200738741A (en) Antiviral compounds
TW200738742A (en) Antiviral compounds
WO2004096233A3 (en) Nucleoside phosphonate conjugates
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
PT1625126E (pt) Imidazo- e tiazolopiridinas como inibidores de cinase jak3
WO2008005565A3 (en) Antiviral phosphinate compounds
MXPA05011294A (es) Compuestos de fosfonato anti-inflamatorios.
TW200519096A (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
WO2004096287A3 (en) Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
TWI264437B (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
WO2007014352A3 (en) Antiviral phosphonate conjugates for inhibition of hiv
WO2004096237A3 (en) Phosphonate analogs for treating metabolic diseases
MXPA05011289A (es) Compuestos de fosfato que tienen actividad inmunomoduladora.
MXPA05011287A (es) Analogos de fosfonato anti-cancer.
UA92464C2 (en) Antiviral compounds
WO2006047507A3 (en) Phosphonate substituted kinase inhibitors
UA96295C2 (en) Antiviral phosphinate compounds
BRPI0409679A (pt) compostos antiinflamatórios de fosfonato

Legal Events

Date Code Title Description
FA Abandonment or withdrawal